D116 Unit 3 Study Guide

D116 Unit 3 Study Guide

Student Name

Western Governors University

D116 Advanced Pharmacology for the Advanced Practice Nurse

Prof. Name:

Date

Unit 3 Study Guide

Review Table 12.2: Discuss the Location and Response of Cholinergic Receptor Subtypes

Cholinergic receptors are classified into muscarinic and nicotinic subtypes, each with distinct anatomical locations and physiological responses. These receptors mediate the actions of acetylcholine within the central and peripheral nervous systems. Understanding receptor distribution is critical for anticipating both therapeutic effects and adverse reactions of cholinergic and anticholinergic medications.

Discuss Pramipexole: What Is the Drug Class, Mechanism of Action, and Clinical Uses?

Pramipexole (Mirapex) belongs to the class of nonergot dopamine receptor agonists. It is primarily utilized in the management of Parkinson’s disease (PD) and restless legs syndrome (RLS).

Mechanism of Action

Pramipexole selectively stimulates dopamine D2 and D3 receptors, with its therapeutic benefits largely attributed to D2 receptor activation. By directly mimicking dopamine in the basal ganglia, pramipexole compensates for dopamine deficiency characteristic of Parkinson’s disease.

Clinical Uses

In early-stage Parkinson’s disease, pramipexole may be used as monotherapy. In more advanced stages, it is commonly combined with levodopa to reduce motor fluctuations. Additionally, pramipexole is FDA-approved for moderate to severe restless legs syndrome.

Discuss the Use of Ergot Derivatives in Parkinson’s Disease

Ergot-derived dopamine agonists, such as bromocriptine and cabergoline, were historically used in Parkinson’s disease management. However, their use has significantly declined.

Limitations of Ergot Derivatives

Although these agents activate dopamine receptors, they also antagonize serotonergic and α-adrenergic receptors. This lack of selectivity increases the risk of adverse effects, including cardiac valvulopathy and fibrotic complications, leading to their avoidance in contemporary Parkinson’s disease treatment.

What Is the Best Treatment for Restless Legs Syndrome?

The first-line pharmacologic treatment for moderate to severe restless legs syndrome is pramipexole, due to its dopaminergic activity and favorable efficacy profile. Restless legs syndrome is characterized by uncomfortable lower-extremity sensations that provoke an urge to move, particularly during periods of rest.

Gabapentin is also commonly used, especially in patients with comorbid neuropathic pain or sleep disturbances, offering an alternative mechanism of symptom control.

Primary Treatment of Cluster Headaches Is Aimed at Prevention: Discuss the Drug Class Used for Prophylaxis

Preventive therapy for cluster headaches focuses on reducing attack frequency and severity. Several medication classes are employed for prophylaxis:

Differentiate Between Preventative Migraine Medication Classes and Abortive Migraine Medication Classes

Migraine pharmacotherapy is divided into abortive and preventive strategies, depending on treatment goals.

Abortive Migraine Therapy

The objective of abortive therapy is to terminate an active migraine attack and alleviate associated symptoms such as nausea and vomiting. These agents are taken at the onset of symptoms.

• Nonspecific agents: NSAIDs and opioid analgesics

• Migraine-specific agents: Triptans (serotonin 5-HT1B/1D agonists) and ergot alkaloids

Preventative Migraine Therapy

Preventive medications are used to decrease migraine frequency and severity over time.

Discuss the Goal for Drug Therapy in a Patient With Schizophrenia

The primary objective of pharmacologic therapy in schizophrenia is relapse prevention and symptom stabilization. Maintenance treatment with antipsychotic medications significantly reduces the likelihood of acute psychotic episodes, although it may not fully prevent long-term cognitive or functional decline.

When Managing a Patient With Depression, What Is the Plan for Follow-Up Regarding Medication Management?

Ongoing assessment is essential when treating depression pharmacologically. Follow-up should focus on evaluating therapeutic response, side effects, and patient safety, including monitoring for suicidal ideation.

Medication Evaluation Timeline

After initiating antidepressant therapy, the medication should be continued for 4 to 8 weeks to assess effectiveness. Dosages are typically started low and titrated upward to minimize adverse effects.

If Initial Therapy Is Ineffective, the Following Options May Be Considered:

• Increase the dosage

• Switch to another medication within the same class

• Switch to a different antidepressant class

• Add an adjunctive agent, such as an atypical antidepressant

Discuss the Adverse Reactions Associated With Lithium Toxicity: What Lab Values Are Considered Therapeutic?

Lithium has a narrow therapeutic index, making laboratory monitoring essential.

Therapeutic serum levels generally range from 0.6 to 1.2 mEq/L, depending on the clinical indication.

Review the Mechanism of Action and Adverse Effects for Atypical Antidepressants

Atypical antidepressants act through varied mechanisms, including dopamine and norepinephrine reuptake inhibition or serotonin receptor modulation.

Common Adverse Effects

Frequently reported side effects include agitation, headache, dry mouth, constipation, gastrointestinal upset, weight loss, dizziness, tremor, insomnia, blurred vision, and tachycardia. Individual drug profiles may vary.

Differentiate Between Reversible and Irreversible Cholinesterase Inhibitors: What Are the Indications for Each?

Cholinesterase inhibitors enhance cholinergic transmission by preventing acetylcholine breakdown.

Reversible agents are preferred clinically due to their safer and more predictable effects.

What Precautions and Patient Education Are Required for Patients Using Clonidine Patches?

Clonidine is a centrally acting α2-adrenergic agonist approved for hypertension, severe pain, and ADHD.

Patient Education and Monitoring

Patients should be instructed to:

• Monitor and record blood pressure daily

• Apply patches to clean, hairless, intact skin on the upper arm or torso

• Replace the transdermal patch every 7 days

• Avoid abrupt discontinuation to prevent rebound hypertension

References

American Psychiatric Association. (2022). Practice guideline for the treatment of patients with schizophrenia. APA Publishing.

Katzung, B. G., Vanderah, T. W., & Trevor, A. J. (2021). Basic & clinical pharmacology (15th ed.). McGraw-Hill Education.

D116 Unit 3 Study Guide

Stahl, S. M. (2021). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (5th ed.). Cambridge University Press.

UpToDate. (2024). Pharmacologic management of Parkinson disease and migraine disorders. Wolters Kluwer.